For the first time a health authority recognizes that probiotics, particularly Lallemand Health Solutions strains Bifidobacteria infantis Rosell®-33, and Bifidobacteria bifidum Rosell®-71,…
Lallemand Health Solutions inaugurated its ultra-modern probiotic bacteria production plant, Harmonium II, with elected officials from the Mirabel region, Ms. Sylvie D’Amours,…
The Rosell® Institute for Microbiome and Probiotics by Lallemand reconducts its platinum sponsorship of the Canadian microbiome symposium, Having IMPACTT, for a…
Sara Caballero Calero, M.Sc. Clinical Research Specialist at the Rosell® Institute from Microbiome and Probiotics by Lallemand, will be the guest speaker…
Lallemand Health Solutions has gained innovative indications for its probiotic strain L. rhamnosus HA-114 from Health Canada, recognizing its beneficial impact to…
Lallemand Health Solutions’ team has some amazing novelties to tell you about at Vitafoods Europe in Geneva Palexpo, Switzerland from May 10-12,…
Annie Tremblay, Scientific Writer at Lallemand Health Solutions will present “Preclinical and Clinical Studies Shed Light on Potential Modes of Action of…
Lallemand Health Solutions has gained new indication for its probiotic strain L. paracasei HA-196 from Health Canada recognizing its beneficial effects to…
Lallemand Health Solutions’ team will be happy to meet and greet you at booth #4370 during the Natural Products Expo West in…
Alex Parker and members of his laboratory at the CHUM Research Centre (CRCHUM) have been awarded a three-year $1.6 million grant from…
